Pancreatic adenocarcinoma Trials in Dallas, United States
Conditions / Pancreatic adenocarcinoma / Dallas, United States
Pancreatic adenocarcinoma is a medical condition with active clinical research programs worldwide.
15 total trials for this combination
Showing top 10 of 15 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT06778863 | A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation | RECRUITING | PHASE1 |
| NCT06399757 | A Study to Investigate APL-5125 in Adults With Advanced Solid Tumors | RECRUITING | PHASE1/PHASE2 |
| NCT05059444 | ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation | RECRUITING | — |
| NCT07349537 | Study of RMC-5127 in Patients With Advanced KRAS G12V-Mutant Solid Tumors | RECRUITING | PHASE1 |
| NCT05208762 | A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors | RECRUITING | PHASE1 |
| NCT02562716 | S1505: Combination Chemotherapy or Gemcitabine Hydrochloride and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Before Surgery in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery | COMPLETED | PHASE2 |
| NCT02839343 | Combination Chemotherapy With or Without Hypofractionated Radiation Therapy Before Surgery in Treating Patients With Pancreatic Cancer | UNKNOWN | PHASE2 |
| NCT05245500 | Phase 1 Study of MRTX1719 in Solid Tumors With MTAP Deletion | RECRUITING | PHASE1 |
| NCT03678883 | 9-ING-41 in Patients with Advanced Cancers | ACTIVE_NOT_RECRUITING | PHASE2 |
| NCT06115499 | The PLATINUM Trial: Optimizing Chemotherapy for the Second-Line Treatment of Metastatic BRCA1/2 or PALB2-Associated Metastatic Pancreatic Cancer | ACTIVE_NOT_RECRUITING | PHASE2/PHASE3 |